Product Information
NABUMETONE 750 MG TABLET is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.1833 per EA under NDC 76282025801. Its NADAC has been published 638 times since Jul 16, 2014.
FDA first approved this application on Mar 7, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
750 mg/1
Manufacturer
Exelan Pharmaceuticals Inc.NDC
76282025801
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NABUMETONEApproval Type
Generic (ANDA)
FDA Application
ANDA078671FDA Approved
3/7/2008
TE Code
AB
On Market Since
4/14/2015
Pharmacological Classes
Price Statistics
The NADAC for NABUMETONE 750 MG TABLET has been published 638 times since Jul 16, 2014, and over the history we have for it it has declined 23.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1833 per EA |
|---|---|
| All-time high | $0.3534 (Jul 14, 2021) |
| All-time low | $0.1082 (Jul 17, 2024) |
| 52-week high | $0.1833 |
| 52-week low | $0.1407 |
| Median price | $0.2211 |
| Average price | $0.2229 |
| Largest weekly change | +69.5% (Aug 21, 2024) |
| Weeks tracked | 638 |
| Tracking since | Jul 16, 2014 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Exelan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nabumetone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NABUMETONE 750 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NABUMETONE 750 MG TABLET, manufactured by Exelan Pharmaceuticals Inc., is $0.1833 per EA (NDC 76282025801), effective Sep 30, 2026.
How has the price of NABUMETONE 750 MG TABLET changed over time?
Over the history we have for it, the NADAC for NABUMETONE 750 MG TABLET has declined 23.4%. It has been tracked across 638 weekly CMS publications since Jul 16, 2014.
What are the highest and lowest recorded NADAC prices for NABUMETONE 750 MG TABLET?
Since Jul 16, 2014, the NADAC for NABUMETONE 750 MG TABLET has ranged from a low of $0.1082 (Jul 17, 2024) to a high of $0.3534 (Jul 14, 2021), with a median of $0.2211 per EA.
Are there cheaper alternatives to NABUMETONE 750 MG TABLET?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as NABUMETONE 750 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures NABUMETONE 750 MG TABLET?
NABUMETONE 750 MG TABLET (NDC 76282025801) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.